Ever Source Wealth Advisors, LLC Bei Gene, Ltd. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 30 shares of BGNE stock, worth $6,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 17
76.47%
Holding current value
$6,029
Previous $2,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BGNE
# of Institutions
254Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.12 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.29 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.04 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1 Billion0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$745 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $20.8B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...